Article Details
Retrieved on: 2021-05-03 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley analysts downgraded BMS' stock from overweight to equal weight last week, noting that they're “uninspired” by the company's drugs ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here